Comparator: Sitagliptin

DRUG5 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Diabetes Mellitus, Non-Insulin-DependentDiabetes Mellitus, Type 2Type 2 Diabetes

Phase 1

A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Concomitant Administration of Sitagliptin and Metformin as Individual Tablets (0431A-048)

CompletedNCT00961857

Merck Sharp & Dohme LLCType 2 Diabetes

Start: 2005-12-01End: 2006-01-01Updated: 2019-11-13

A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Co-administration of Sitagliptin and Metformin as Individual Tablets (0431A-095)

CompletedNCT00961480

Merck Sharp & Dohme LLCType 2 Diabetes

Start: 2007-10-31End: 2007-11-30Updated: 2015-06-09

Phase 2

Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)

CompletedNCT00758069

Merck Sharp & Dohme LLCDiabetes Mellitus, Non-Insulin-Dependent

Start: 2005-07-03End: 2006-02-13Updated: 2017-05-05

Phase 3

Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus

CompletedNCT00086502

Merck Sharp & Dohme LLCDiabetes Mellitus, Type 2

Start: 2004-06-30End: 2005-11-30Updated: 2016-02-05

Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)

CompletedNCT00106704

Merck Sharp & Dohme LLCDiabetes Mellitus, Type 2

Start: 2005-03-31End: 2007-01-31Updated: 2015-07-01